MBXBF News Alert Microbix Biosystems (MBXBF) 0.5191 10/15/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Microbix Biosystems (MBXBF) 0.5191 $MBXBF

IIROC Trade Resumption - Microbix Biosystems Inc.
Newsfile Corp - Fri Aug 22, 12:57PM CDT
Trading resumes in:

IIROC Trade Halt - Microbix Biosystems Inc.
Newsfile Corp - Fri Aug 22, 12:17PM CDT
The following issues have been halted by IIROC:

eResearch Posts Update Report on Microbix Biosystems Inc.
ACCESSWIRE - Wed Feb 26, 1:52PM CST
Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.
MBX.TO: 0.55 (-0.02)

eResearch Posts Perspective on Microbix Biosystems Inc.
ACCESSWIRE - Mon Aug 19, 9:19AM CDT
Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.
MBX.TO: 0.55 (-0.02)

Competitor Analysis: Thrombolytics & Fibrinolytics
M2 - Mon May 20, 3:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3c6qc/competitor) has announced the addition of the "Competitor Analysis: Thrombolytics & Fibrinolytics" report to their offering. The Competitive Intelligence Report Thrombolytics & Fibrinolytics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel thrombolytics and fibrinolytics for treatment of cardiovascular thrombosis, stroke and eye diseases. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. The report provides information on the various generation of marketed thrombolytics and includes a compilation of current active projects in research and development of novel thrombolytics and fibrinolytics including those in development in ophthalmology and in less regulated markets. In addition, the report lists company-specific product portfolios and R&D pipelines of thrombolytics and fibrinolytics. Competitor projects are listed in a tabular format providing information on: - Drug Codes, - Target / Mechanism of Action, - Class of Compound, - Company, - Product Category, - Indication, - R&D Stage and - additional comments with a hyperlink leading to the source of information. Examples of Companies Mentioned - Actavis - Alcon - Astellas Pharma - Bharat Biotech - Biocon - BioGeneric Pharma - Cadila Pharma - Cerbios Pharma - Cerevast Therapeutics - CSL Behring - Dexa Medica - Eisai - Ekos Corp - Grifols - Heber Biotec - Kedrion - Kee Pharma - Lundbeck - Microbix Biosystems - Mitsubishi Tanabe Pharma - Nanogen Biopharmaceuticals - ProteomTech - Pulse Therapeutics - Roche (Genentech) - Shantha Biotechnics (Sanofi) - Techpool BioPharma - Thrombogenics - Zydus Cadila For more information visit http://www.researchandmarkets.com/research/j3c6qc/competitor About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Microbix reports fiscal 2013 first quarter results
CNW Group - Thu Feb 14, 6:30AM CST
Company Provides Update on Product Pipeline
MBX.TO: 0.55 (-0.02)

Microbix Sells Purified Water Business
CNW Group - Fri Feb 01, 6:30AM CST
Microbix Biosystems Inc. (TSX: MBX), a biotechnology company developing innovative biological products and technologies, today announced it has sold its Water-for-Injection business to Irvine Scientific in California. The sale was constructed on an earn-out basis, though specific deal terms were not disclosed.
MBX.TO: 0.55 (-0.02)

Microbix' LumiSort Patent Upheld in U.S.
CNW Group - Fri Jan 25, 6:25AM CST
Sexing Technologies fails in second attempt to invalidate claims
MBX.TO: 0.55 (-0.02)

Microbix Refiles Financial Statements
CNW Group - Thu Jan 10, 4:41PM CST
Microbix Biosystems Inc. (TSX:MBX) today refiled its financial statements for the year ended September 30, 2012 to correct two oversights in the Consolidated Statements of Comprehensive Loss.
MBX.TO: 0.55 (-0.02)

Microbix Reports 15% Increase In Virology Product Sales In 2012
CNW Group - Fri Dec 28, 10:33PM CST
Urokinase, Vaccine Venture, and LumiSort Update
MBX.TO: 0.55 (-0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 101

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 0

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach

Updated Category News Views 39

Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...

Continue Reading
Zensar’s AI Forum Puts Operations Before the AI Hype

Updated Category News Views 111

Johannesburg’s AI conversation seems to be shedding its costume jewelry at last. Zensar’s invitation-only CIS Converge 2026 forum, held on November 20, put the attention where it belongs: not on breathless demos, but on whether companies can turn AI into sturdier operations, better customer experiences, and something resembling a measurable return. That is a healthier...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 25

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
IAS Marks 42 Years Amid Germany Religious Freedom Win

Updated Category News Views 96

Bagpipes, country roads and a gathering from six continents made this far more than a routine anniversary reception. The International Association of Scientologists marked its 42nd anniversary at Saint Hill in East Grinstead, England, with thousands of Scientologists and guests arriving as autumn settled over West Sussex. That sort of turnout is a visible statement of...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 41

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 126

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Faces Setback as Entresto Generic Approved

Updated Category News Views 393

Novartis' Legal Challenges with Entresto Generic Novartis, a leading pharmaceutical company, recently encountered a significant setback in its attempts to block the launch of a generic version of its heart-failure medication, Entresto. A federal judge in Washington, D.C., ruled against Novartis', effectively paving the way for MSN Pharmaceuticals to release its generic...

Continue Reading
Walk-On's Partners with Port Royal for Expansive Growth

Updated Category News Views 581

Walk-On's Sports Bistreaux Announces Major Development Deal Walk-On's Sports Bistreaux is thrilled to announce a pivotal partnership with Port Royal Brands, marking a significant step forward in its expansion plans. This exciting collaboration will encompass the development of 20 new restaurants, aiming to bring the spirit of family-friendly sports dining to new...

Continue Reading
Gabelli Healthcare & Wellness Trust Announces Quarterly $0.17 Distribution

Updated Category News Views 152

Gabelli Healthcare & Wellness Trust Declares Cash Distribution The Board of Trustees of The Gabelli Healthcare & Wellness Trust (NYSE: GRX) has announced a cash distribution of $0.17 per share. This distribution is set to be paid to common shareholders on a specified date. The Board's decision reflects ongoing efforts to provide regular income to investors. Distribution...

Continue Reading
Faraday Future Prepares for Third Quarter Earnings Call

Updated Category News Views 119

Faraday Future Announces Earnings Conference Call Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) is excited to share the timeline for its scheduled earnings conference call focused on its third quarter results for 2024. This highly anticipated call will occur after market hours, specifically on a Wednesday evening, at 5:00 p.m. Pacific Time. Investors and...

Continue Reading
Chicagoland Leaders Rally to Support Local Black Businesses

Updated Category News Views 123

Community Leaders Unite for Local Black Businesses In a powerful display of solidarity, community leaders and clergy in Chicagoland are calling on the City Council to take decisive action in support of local Black-owned businesses. One business at the heart of this effort is Island Furs, a beloved fixture that has proudly served the community for over 30 years. The...

Continue Reading